Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Controlled Study of Low Concentration Atropine in the Prevention of Myopia in Pre-myopia Children.

NCT05939882 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.

NCT NCT05939882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Controlled Study of Low Concentration Atropine in the Prevention of Myopia in Pre-myopia Children.
Lead sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2023
Completion date
April 30, 2024
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia, progressive